PLG and Parkinson disease: Although the findings are interesting, especially considering the poor treatment choices that are currently available and the devastating nature of this disease, additional preclinical and clinical studies are needed to fully understand the molecular mechanisms and clinical efficacy of plasminogen in PD treatment.